Sign in

You're signed outSign in or to get full access.

Company not found (MODV)

Earnings summaries and quarterly performance for MODV.

Recent press releases and 8-K filings for MODV.

ModivCare Reports Q4 and Full Year 2024 Results, Announces Capital Raise and Strategic Divestiture Plans
MODV
Earnings
Debt Issuance
M&A
  • ModivCare reported Q4 2024 revenue of $702.8 million and adjusted EBITDA of $40.4 million, bringing full-year 2024 revenue to $2.8 billion and adjusted EBITDA to $161.1 million. The company recorded a consolidated net loss of $23.5 million for Q4 2024.
  • To strengthen its capital position, ModivCare secured an incremental $75 million term loan and $30 million in new second lien notes, which require shareholder approval on March 13, 2025. The company ended the year with $113 million in cash.
  • ModivCare is pursuing strategic divestitures of select platforms, with the monitoring platform being the most advanced in the process, and appointed Alec Cunningham and David Mounts Gonzalez to its Board of Directors effective March 7, 2025.
  • The NEMT segment experienced a net business loss of approximately $200 million in annual revenue for 2025 due to contract attrition but expects to recover materially from an active pipeline exceeding $300 million in annual contract value.
  • The company is transitioning to a fee-for-service contract model to improve cash flow and reduce utilization risk, with approximately 25% of its revenue already converted to this structure.
Mar 6, 2025, 10:00 PM
ModivCare Reports Q4 and Full Year 2024 Results, Announces Capital Strengthening and Divestiture Plans
MODV
Earnings
Debt Issuance
M&A
  • ModivCare reported Q4 2024 revenue of $702.8 million and full-year 2024 revenue of $2.8 billion, with adjusted EBITDA of $40.4 million for Q4 and $161.1 million for the full year. The company also reported a Q4 2024 consolidated net loss of $23.5 million and adjusted net income of $2.7 million, or $0.19 per share.
  • To strengthen its capital position, ModivCare secured an incremental $75 million term loan and $30 million in new second lien notes, with the latter requiring shareholder approval on March 13, 2025.
  • The company has launched a divestiture process, with its monitoring platform being the most advanced in this effort, and is transitioning to a fee-for-service contract model, with approximately 25% of its revenue already converted to this structure.
  • ModivCare will not provide formal fiscal 2025 guidance due to an ongoing strategic review and anticipated material portfolio changes, but expects NEMT margins to be relatively flat year-over-year in 2025 before normalizing to 8-10% EBITDA in 2026.
Mar 6, 2025, 10:00 PM